What Perceptive does

Perceptive is a privately held, science-led clinical research services provider headquartered in London, with operations spanning preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM). The company is organized into three operating divisions — Perceptive Discovery (preclinical imaging, radiochemistry, biodistribution, and binding assays), Perceptive eClinical (IRT/RTSM, with the ClinPhone Pro platform, plus eCOA and Clinical Intelligence), and Perceptive Imaging (imaging core lab and in-house imaging centers in London and New Haven). Its technology stack combines proprietary software (VivoQuant for preclinical image analysis, ClinPhone Pro for cloud-native RTSM, and iPACS for workflow management) with multi-modality imaging capabilities across PET, SPECT, MRI, CT, and optical platforms, and GMP radiotracer manufacturing.

The company serves global biopharmaceutical sponsors and CROs, with a strong specialty focus on radiopharmaceutical therapy and theranostics (supporting 80% of radioligand therapy companies), oncology (1,800+ solid tumor trials), CNS (770+ trials), and rare diseases. It has supported 11,000+ trials, 800+ regulatory approvals across FDA, EMA, and NMPA, and randomized 3M+ participants through its IRT systems. Named customers include ArriVent, LG Chem, Veralox Therapeutics, ClinChoice, and ProTrials. Distribution is enterprise-direct with CRO channel partnerships, and services are quote-based professional engagements plus recurring platform subscriptions on ClinPhone Pro.

Revenue is not publicly disclosed. Growth is being driven by a cluster of recent moves: the May 2025 launch of ClinPhone Pro, a January 2026 $15M investment from CapVest, and 2026 alliances with Trialzen (clinical supply intelligence), Kayentis (eCOA), and MH3D (α-Sight alpha radiopharmaceutical imaging), alongside a 5x expansion of its Needham preclinical lab. The company maintains a zero-observation regulatory inspection record over the past decade and is recognized as the #1 Market Impact leader in Everest Group's 2025 PEAK Matrix for RTSM Solutions.

Name

Perceptive

Legal name

Perceptive

Website

https://perceptive.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Perceptive is a London-based clinical research services provider offering preclinical imaging, clinical trial imaging, and IRT/RTSM solutions to global biopharmaceutical sponsors and CROs, with deep specialization in radiopharmaceutical therapy and oncology.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK)

akta.pro secondary industry

Data Management, Biostatistics & Statistical Programming FSP (HLAGAOAB)

Keywords

• Clinical trial imaging
• Preclinical imaging services
• Randomization trial supply
• Medical imaging core lab
• Radiochemistry services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Imaging Core Lab Services: Fees for clinical trial imaging services including centralized blinded independent reads, quantitative image analysis, site qualification and training, and regulatory-compliant data management across all phases of clinical development.
2. IRT/RTSM Technology and Services: Interactive Response Technology platform and randomization services for clinical trials, supporting all phases and therapeutic areas with dedicated project management and consultancy.
3. Preclinical Imaging and Radiochemistry Services: Discovery-phase imaging services including biodistribution studies, efficacy modeling, dosimetry, and radiolabeling services for drug development programs.
4. Clinical Intelligence Consultancy: Technology-enabled consultancy service combining clinical supply expertise with advanced forecasting technology, generating reported savings exceeding $1 million per study for sponsors.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Perceptive delivers preclinical and clinical medical imaging core lab services, randomization and trial supply management (IRT/RTSM) via the ClinPhone Pro platform, electronic clinical outcome assessments (eCOA), radiochemistry, biodistribution and radioligand binding assay services, and clinical trial adjudication for pharmaceutical, biotechnology, and medical device sponsors. The company supports more than 11,000 trials and 800 regulatory approvals with a workforce of 3,000+ professionals across its integrated preclinical-to-clinical continuum.

Product overview

Perceptive is a science-led provider offering preclinical imaging, clinical trial imaging, and randomization and trial supply management (RTSM) services. The company's product portfolio consists of three interconnected service pillars: (1) Discovery/Preclinical services including Preclinical Imaging, Radiochemistry, Biodistribution Services, and Radioligand Binding Assay Services; (2) eClinical solutions including IRT/RTSM (ClinPhone Pro platform), eCOA module, and Clinical Intelligence consultancy; and (3) Clinical Imaging services including Imaging Core Lab and In-House Clinical and Imaging Centers. Supporting these core offerings is the VivoQuant™ software platform for preclinical image analysis. The integrated ecosystem enables sponsors to move from early discovery through late-phase clinical trials, with specialized expertise in oncology, CNS, radiopharmaceutical therapy, and rare diseases.

Differentiator

Problem solved

Functional benefit

Brands

• ClinPhone Pro: Next-generation IRT/RTSM platform for clinical trial randomization and supply management
• VivoQuant™
• Perceptive Clinical Intelligence
• α-Sight™

Products and services

• Clinical Imaging Core Lab Centralized medical imaging core lab services for clinical trials, including image acquisition standards, blinded independent central review, and quantitative endpoint analysis for pharmaceutical and biotech sponsors across therapeutic areas including oncology.
• Preclinical Imaging Preclinical imaging services and image analysis software (VivoQuant) supporting early-stage drug development, biodistribution studies, and translational research for pharmaceutical and biotech R&D teams.
• IRT/RTSM (ClinPhone Pro) Randomization and Trial Supply Management (IRT/RTSM) software platform used to randomize patients, manage drug supply logistics, and maintain blinding in clinical trials for pharmaceutical and biotech sponsors.
• Electronic Clinical Outcome Assessment (eCOA) Electronic Clinical Outcome Assessment platform for capturing patient-reported outcomes, clinician-reported outcomes, and performance outcomes in clinical trials, deployed for pharmaceutical and biotech sponsors.
• Radiochemistry Services Specialized radiochemistry services supporting the development and manufacture of radiolabeled compounds for imaging and radioligand therapy studies in clinical and preclinical development.
• Biodistribution Services Biodistribution studies and analyses, including quantitative tissue distribution assessments, supported by the α-Sight workflow tool, for sponsors developing radiopharmaceuticals and imaging agents.
• Radioligand Binding Assay Services Radioligand binding assay services supporting in vitro characterization of receptor-ligand interactions for radiopharmaceutical and central nervous system drug development programs.
• Clinical Trial Adjudication Services Independent endpoint adjudication committee management and event adjudication services for clinical trials requiring blinded expert review of safety or efficacy events.
• In-House Clinical and Imaging Centers Dedicated in-house clinical and imaging facilities enabling Perceptive to conduct imaging and early-phase clinical studies directly for sponsors, with full control over imaging protocols and study execution.

Quantifiable outcome

• Real-world engagements generating savings exceeding $1 million per study through clinical supply optimization
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability5 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• TrialzencoreStrategic or Co-development Partner · 27 April 2026Perceptive eClinical and Trialzen announced an alliance to launch Perceptive Clinical Intelligence, a technology-enabled clinical supply consultancy service that combines Perceptive's randomization and supply optimization expertise with Trialzen's advanced forecasting and simulation technologies. The service addresses industry inefficiency where approximately 50% of clinical finished goods manufactured for trials are never administered to patients. Engagements reportedly generate savings exceeding $1 million per study and are fully integrated into Perceptive's ClinPhone Pro platform.
• MH3DcoreTechnology or Integration · 15 April 2026Perceptive Discovery announced a strategic partnership with MH3D and launched α-Sight, a preclinical imaging service enabling direct in vivo visualization of alpha-emitting radiopharmaceuticals. The offering integrates MH3D's Alpha-SPECT Mini CZT-based detection platform with Perceptive Discovery's preclinical imaging, radiochemistry, and quantitative image analysis expertise. Perceptive Discovery serves as MH3D's exclusive service provider. α-Sight supports biodistribution studies, tumor targeting validation, and PK/PD assessment to help accelerate radioligand therapy development programs.
• KayentiscoreStrategic or Co-development Partner · 24 March 2026Perceptive eClinical and Kayentis formed a strategic partnership to deliver an integrated eCOA-IRT solution for clinical trials. The partnership addresses industry challenge of digital system fragmentation where sites often use up to 17 different systems in a single study. The joint offering combines Perceptive's Interactive Response Technology expertise with Kayentis' electronic Clinical Outcome Assessment capabilities to streamline trial execution, reduce site workload, and lower study costs through automatic data transfer and workflow integration. Both companies view this as the beginning of broader interoperability expansion across the clinical trial lifecycle.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• IQVIA: The largest global CRO and life sciences technology vendor. Overlaps directly with Perceptive in clinical trial imaging, IRT/RTSM, and preclinical-to-Phase III execution, but operates as a full-service, broad-portfolio incumbent rather than an imaging- and eClinical-focused specialist.
• ICON plc: Top-five global CRO following the PRA Health Sciences merger, with significant imaging core lab, RTSM, and clinical operations capabilities. Comparable because it competes for the same enterprise pharma imaging and eClinical contracts as Perceptive, though at much larger scale.
• Labcorp (incl. Covance/Fortrea): Broad clinical laboratory and CRO services business (with Fortrea spun out as a focused CRO). Comparable to Perceptive in central lab, imaging, and trial supply management, though it spans diagnostic testing, routine labs, and drug development.
• Parexel International: Large global CRO (private-equity-owned) with full-service clinical, biostatistics, and RTSM offerings. Competes with Perceptive for enterprise sponsor imaging and randomization contracts and shares the same end customers.
• Veeva Systems: Cloud platform provider for life sciences, with Veeva Vault CDMS, eTMF, and clinical operations software used by the same sponsors Perceptive serves. Adjacent and partially overlapping with ClinPhone Pro and Perceptive's eClinical roadmap.

Direct peers

• Medpace: Mid-sized, profitable CRO focused on small-to-mid biotech sponsors across all phases. Overlaps with Perceptive in clinical operations, imaging, and lab services, and is one of the most directly comparable CRO peers in terms of sponsor mix and therapeutic focus.
• Clario (formerly ERT/Bioclinica): Specialty provider of clinical trial endpoint technologies including eCOA, cardiac safety, and imaging core lab services. Direct competitor to Perceptive Imaging and to ClinPhone Pro in eClinical, with deep scientific expertise in imaging endpoints.
• Charles River Laboratories: Major preclinical CRO with discovery, safety assessment, and imaging services. Comparable to Perceptive Discovery on the preclinical imaging and radiochemistry side and overlaps in early-stage oncology and CNS sponsors.
• BioClinica (now part of Clario): Long-standing imaging core lab for oncology and CNS trials, now part of Clario. One of Perceptive's closest direct competitors in clinical trial imaging, particularly in oncology and neurodegenerative disease programs.

Emerging players

• 4G Clinical: Specialty RTSM/IRT vendor competing with ClinPhone Pro. Comparable as a focused eClinical randomization vendor and a peer in Everest Group's RTSM PEAK Matrix alongside Perceptive.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/perceptive-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Perceptive